Low	O
CD3+CD28-induced	O
interleukin-2	B-protein
production	O
correlates	O
with	O
decreased	O
reactive	O
oxygen	O
intermediate	O
formation	O
in	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
capacity	O
of	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
to	O
secrete	O
interleukin-2	B-protein
(	O
IL-2	B-protein
)	O
has	O
been	O
reported	O
to	O
be	O
variable	O
.	O

We	O
analysed	O
IL-2	B-protein
production	O
in	O
purified	O
neonatal	B-cell_type
and	I-cell_type
adult	I-cell_type
T	I-cell_type
cells	I-cell_type
using	O
polyclonal	O
activator	O
phorbol	O
ester	O
+	O
calcium	O
ionophore	O
(	O
PDBu	O
+	O
iono	O
)	O
or	O
receptor-mediated	O
anti-CD3	B-protein
/anti-CD3+	O
anti-CD28	B-protein
stimulation	O
.	O

PDBu	O
+	O
iono	O
induced	O
equally	O
high	O
IL-2	B-protein
levels	O
in	O
both	O
groups	O
and	O
,	O
when	O
stimulated	O
with	O
plate-bound	O
anti-CD3	B-protein
monoclonal	I-protein
antibody	I-protein
(	O
mAb	B-protein
)	O
,	O
the	O
IL-2	B-protein
secretion	O
by	O
neonatal	B-cell_type
cells	I-cell_type
was	O
undetectable	O
and	O
adult	B-cell_type
cells	I-cell_type
produced	O
low	O
amounts	O
of	O
IL-2	B-protein
(	O
mean	O
331	O
+/-	O
86	O
pg/ml	O
)	O
.	O

The	O
addition	O
of	O
anti-CD28	B-protein
mAb	I-protein
to	O
anti-CD3-stimulated	B-cell_line
cells	I-cell_line
markedly	O
increased	O
IL-2	B-protein
production	O
in	O
both	O
cell	O
types	O
,	O
but	O
levels	O
of	O
IL-2	B-protein
in	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
remained	O
clearly	O
lower	O
than	O
those	O
of	O
adult	B-cell_type
T	I-cell_type
cells	I-cell_type
(	O
respective	O
mean	O
values	O
:	O
385	O
+/-	O
109	O
pg/ml	O
and	O
4494	O
+/-	O
1199	O
pg/ml	O
)	O
.	O

As	O
NF-kappa	B-protein
B	I-protein
is	O
a	O
critical	O
transcription	B-protein
factor	I-protein
in	O
the	O
control	O
of	O
IL-2	B-protein
expression	O
,	O
we	O
next	O
analysed	O
its	O
nuclear	O
translocation	O
in	O
neonatal	B-cell_type
and	I-cell_type
adult	I-cell_type
T	I-cell_type
cells	I-cell_type
using	O
the	O
electrophoretic	O
mobility	O
shift	O
assay	O
and	O
,	O
because	O
induction	O
of	O
reactive	O
oxygen	O
intermediates	O
(	O
ROI	O
)	O
is	O
required	O
for	O
the	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
,	O
we	O
also	O
analysed	O
levels	O
of	O
intracellular	O
ROI	O
in	O
these	O
cells	O
using	O
the	O
ROI-reactive	O
fluorochrome	O
DCFH-DA	O
and	O
flow	O
cytometry	O
.	O

In	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
NF-kappa	B-protein
B	I-protein
activation	O
and	O
ROI	O
formation	O
after	O
anti-CD3	B-protein
stimulation	O
were	O
low	O
compared	O
with	O
adult	B-cell_type
T	I-cell_type
cells	I-cell_type
and	O
,	O
although	O
addition	O
of	O
anti-CD28	B-protein
mAb	I-protein
increased	O
induction	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
ROI	O
formation	O
,	O
levels	O
similar	O
to	O
those	O
of	O
adults	O
were	O
not	O
achieved	O
.	O

After	O
PDBu	O
+	O
iono	O
stimulation	O
,	O
the	O
cells	O
showed	O
similar	O
ROI	O
formation	O
and	O
IL-2	B-protein
secretion	O
.	O

Our	O
results	O
suggest	O
that	O
reduced	O
IL-2	B-protein
production	O
by	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
is	O
specific	O
for	O
anti-CD3	B-protein
and	O
anti-CD3	B-protein
+	O
anti-CD28	B-protein
-mediated	O
stimulation	O
and	O
that	O
these	O
activators	O
can	O
not	O
effectively	O
activate	O
the	O
ROI	O
-NF-kappa	B-protein
B	I-protein
signalling	O
pathway	O
in	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Immunology	NULL
1998	NULL
94	NULL
167-172	NULL
Low	NULL
CD3	NULL
+	NULL
CD28-induced	NULL
interleukin-2	NULL
production	NULL
correlates	NULL
with	NULL
decreased	NULL
reactive	NULL
oxygen	NULL
intermediate	NULL
formation	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
S.	NULL
KILPINEN	NULL
&	NULL
M.	NULL
HURME	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Tampere	NULL
Medical	NULL
School	NULL
,	NULL
Tampere	NULL
,	NULL
Finland	NULL
SUMMARY	NULL
The	NULL
capacity	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
to	NULL
secrete	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
variable	NULL
.	NULL

We	NULL
analysed	NULL
IL-2	NULL
production	NULL
in	NULL
purified	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
using	NULL
polyclonal	NULL
activator	NULL
phorbol	NULL
ester	NULL
+	NULL
calcium	NULL
ionophore	NULL
(	NULL
PDBu	NULL
+	NULL
iono	NULL
)	NULL
or	NULL
receptor-mediated	NULL
anti-CD3/anti-CD3	NULL
+	NULL
anti-CD28	NULL
stimulation	NULL
.	NULL

PDBu+iono	NULL
induced	NULL
equally	NULL
high	NULL
IL-2	NULL
levels	NULL
in	NULL
both	NULL
groups	NULL
and	NULL
,	NULL
when	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
,	NULL
the	NULL
IL-2	NULL
secretion	NULL
by	NULL
neonatal	NULL
cells	NULL
was	NULL
undetectable	NULL
and	NULL
adult	NULL
cells	NULL
produced	NULL
low	NULL
amounts	NULL
of	NULL
IL-2	NULL
(	NULL
mean	NULL
331	NULL
+86	NULL
pg/ml	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
to	NULL
anti-CD3-stimulated	NULL
cells	NULL
markedly	NULL
increased	NULL
IL-2	NULL
production	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
but	NULL
levels	NULL
of	NULL
IL-2	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
remained	NULL
clearly	NULL
lower	NULL
than	NULL
those	NULL
of	NULL
adult	NULL
T	NULL
cells	NULL
(	NULL
respective	NULL
mean	NULL
values	NULL
:	NULL
385	NULL
+109	NULL
pg/ml	NULL
and	NULL
4494	NULL
+1199	NULL
pg/ml	NULL
)	NULL
.	NULL

As	NULL
NF-xB	NULL
is	NULL
a	NULL
critical	NULL
transcription	NULL
factor	NULL
in	NULL
the	NULL
control	NULL
of	NULL
IL-2	NULL
expression	NULL
,	NULL
we	NULL
next	NULL
analysed	NULL
its	NULL
nuclear	NULL
translocation	NULL
in	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
using	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
and	NULL
,	NULL
because	NULL
induction	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-xB	NULL
,	NULL
we	NULL
also	NULL
analysed	NULL
levels	NULL
of	NULL
intracellular	NULL
ROI	NULL
in	NULL
these	NULL
cells	NULL
using	NULL
the	NULL
ROI-reactive	NULL
fluorochrome	NULL
DCFH-DA	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

In	NULL
neonatal	NULL
T	NULL
cells	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
ROI	NULL
formation	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
were	NULL
low	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
and	NULL
,	NULL
although	NULL
addition	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
increased	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
ROI	NULL
formation	NULL
,	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
adults	NULL
were	NULL
not	NULL
achieved	NULL
.	NULL

After	NULL
PDBu+iono	NULL
stimulation	NULL
,	NULL
the	NULL
cells	NULL
showed	NULL
similar	NULL
ROI	NULL
formation	NULL
and	NULL
IL-2	NULL
secretion	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
reduced	NULL
IL-2	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
is	NULL
specific	NULL
for	NULL
anti-CD3	NULL
and	NULL
anti-CD3	NULL
+	NULL
anti-CD28-mediated	NULL
stimulation	NULL
and	NULL
that	NULL
these	NULL
activators	NULL
can	NULL
not	NULL
effectively	NULL
activate	NULL
the	NULL
ROI-NF-xB	NULL
signalling	NULL
pathway	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

INTRODUCTION	NULL
Neonatal	NULL
T	NULL
cells	NULL
may	NULL
be	NULL
considered	NULL
as	NULL
naive	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
origin	NULL
,	NULL
their	NULL
phenotype	NULL
and	NULL
their	NULL
functional	NULL
properties	NULL
.	NULL

Tedder	NULL
et	NULL
al	NULL
.	NULL
'	NULL

originally	NULL
made	NULL
the	NULL
observation	NULL
that	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
of	NULL
human	NULL
neonatal	NULL
T	NULL
cells	NULL
are	NULL
of	NULL
the	NULL
CD45RA	NULL
*	NULL
surface	NULL
phenotype	NULL
,	NULL
whereas	NULL
only	NULL
about	NULL
60	NULL
%	NULL
of	NULL
circulating	NULL
adult	NULL
T	NULL
cells	NULL
are	NULL
of	NULL
this	NULL
phenotype	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
these	NULL
CD4SRA	NULL
*	NULL
T	NULL
cells	NULL
are	NULL
virgin	NULL
,	NULL
antigenically	NULL
unprimed	NULL
cells	NULL
that	NULL
evolve	NULL
into	NULL
CD4SRO*	NULL
T	NULL
cells	NULL
-	NULL
memory	NULL
cells	NULL
-	NULL
presumably	NULL
as	NULL
a	NULL
result	NULL
of	NULL
repeated	NULL
antigen	NULL
exposure	NULL
.	NULL

*	NULL
``	NULL
The	NULL
cytokine	NULL
profile	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
is	NULL
unique	NULL
and	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
neonatal	NULL
T	NULL
cells	NULL
produce	NULL
less	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
IL-10	NULL
and	NULL
tumour	NULL
necrosis	NULL
factor-	NULL
«	NULL
(	NULL
TNF-4	NULL
«	NULL
)	NULL
than	NULL
adult	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
.	NULL

**	NULL
Conflicting	NULL
results	NULL
have	NULL
been	NULL
found	NULL
with	NULL
regard	NULL
to	NULL
IL-2	NULL
production	NULL
by	NULL
neonatal	NULL
cells	NULL
:	NULL
increased	NULL
,	NULL
normal	NULL
or	NULL
reduced	NULL
IL-2	NULL
secretion	NULL
have	NULL
all	NULL
been	NULL
Received	NULL
23	NULL
October	NULL
1997	NULL
;	NULL
revised	NULL
26	NULL
February	NULL
1998	NULL
;	NULL
accepted	NULL
28	NULL
February	NULL
1998	NULL
.	NULL

Correspondence	NULL
:	NULL
Dr	NULL
S.	NULL
Kilpinen	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Tampere	NULL
Medical	NULL
School	NULL
,	NULL
P.	NULL
O	NULL
.	NULL

Box	NULL
607	NULL
,	NULL
FIN-33	NULL
101	NULL
,	NULL
Tampere	NULL
,	NULL
Finland	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
reported	NULL
.	NULL

``	NULL
~	NULL
``	NULL
This	NULL
discrepancy	NULL
may	NULL
at	NULL
least	NULL
partially	NULL
be	NULL
caused	NULL
by	NULL
differences	NULL
in	NULL
experimental	NULL
procedures	NULL
and/or	NULL
differences	NULL
in	NULL
stimulating	NULL
agents	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
studies	NULL
have	NULL
been	NULL
carried	NULL
out	NULL
using	NULL
polyclonal	NULL
activators	NULL
and	NULL
,	NULL
in	NULL
response	NULL
to	NULL
them	NULL
,	NULL
IL-2	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
comparable	NULL
with	NULL
IL-2	NULL
production	NULL
by	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
a	NULL
few	NULL
studies	NULL
using	NULL
more	NULL
specific	NULL
stimuli	NULL
,	NULL
like	NULL
antigens	NULL
or	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
mAb	NULL
)	NULL
against	NULL
the	NULL
CD3/T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
complex	NULL
and	NULL
the	NULL
CD2	NULL
molecule	NULL
,	NULL
have	NULL
reported	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
level	NULL
of	NULL
IL-2	NULL
secretion	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
Optimal	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
results	NULL
in	NULL
increased	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
enhanced	NULL
cell	NULL
proliferation	NULL
and	NULL
an	NULL
effective	NULL
immune	NULL
response	NULL
.	NULL
``	NULL

''	NULL
To	NULL
become	NULL
optimally	NULL
activated	NULL
,	NULL
T	NULL
cells	NULL
require	NULL
co-stimulatory	NULL
signals	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
signal	NULL
provided	NULL
via	NULL
the	NULL
CD3/TCR	NULL
complex	NULL
.	NULL

The	NULL
CD28	NULL
molecule	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
important	NULL
co-stimulatory	NULL
receptor	NULL
on	NULL
T	NULL
cells	NULL
and	NULL
addition	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
to	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3/TCR	NULL
mAb	NULL
enhanced	NULL
T-cell	NULL
proliferation	NULL
,	NULL
primarily	NULL
as	NULL
a	NULL
result	NULL
of	NULL
increased	NULL
IL-2	NULL
synthesis	NULL
.	NULL
``	NULL

Signalling	NULL
through	NULL
CD28	NULL
leads	NULL
to	NULL
activation	NULL
and	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
CD28	NULL
responsive	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
in	NULL
the	NULL
IL-2	NULL
pro-moter	NULL
.	NULL
``	NULL

NF-xB	NULL
has	NULL
a	NULL
central	NULL
role	NULL
in	NULL
T-cell	NULL
activation	NULL
and	NULL
is	NULL
168	NULL
S.	NULL
Kilpinen	NULL
&	NULL
M.	NULL
Hurme	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

A	NULL
great	NULL
variety	NULL
of	NULL
stimuli	NULL
can	NULL
regulate	NULL
its	NULL
activation	NULL
.	NULL

'*	NULL
Recent	NULL
evidence	NULL
suggests	NULL
that	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
are	NULL
not	NULL
only	NULL
undesirable	NULL
side-products	NULL
of	NULL
mitochondrial	NULL
respiration	NULL
or	NULL
part	NULL
of	NULL
an	NULL
antimicrobial	NULL
defence	NULL
mechanism	NULL
but	NULL
may	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
of	NULL
immunoregulatory	NULL
processes	NULL
.	NULL
``	NULL

''	NULL
A	NULL
number	NULL
of	NULL
studies	NULL
further	NULL
suggest	NULL
that	NULL
ROI	NULL
,	NULL
for	NULL
example	NULL
superoxide	NULL
,	NULL
hydrogen	NULL
peroxide	NULL
and	NULL
lipoxygenase	NULL
products	NULL
,	NULL
could	NULL
participate	NULL
in	NULL
lymphocyte	NULL
activation	NULL
;	NULL
basically	NULL
all	NULL
inducers	NULL
of	NULL
NF-xB	NULL
,	NULL
such	NULL
as	NULL
viral	NULL
and	NULL
bacterial	NULL
products	NULL
,	NULL
T-cell	NULL
mitogens	NULL
,	NULL
co-stimulation	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
and	NULL
inflammatory	NULL
cytokines	NULL
,	NULL
induce	NULL
a	NULL
transient	NULL
formation	NULL
of	NULL
ROI	NULL
;	NULL
furthermore	NULL
,	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
is	NULL
inhibited	NULL
by	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
chemically	NULL
unrelated	NULL
antioxidants	NULL
.	NULL

'*	NULL
'	NULL
``	NULL
The	NULL
precise	NULL
role	NULL
of	NULL
ROI	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
is	NULL
still	NULL
unknown	NULL
,	NULL
but	NULL
it	NULL
is	NULL
thought	NULL
that	NULL
these	NULL
could	NULL
directly	NULL
modify	NULL
the	NULL
function	NULL
of	NULL
transcription	NULL
factors	NULL
or	NULL
could	NULL
act	NULL
as	NULL
second	NULL
messengers	NULL
,	NULL
to	NULL
regulate	NULL
the	NULL
activity	NULL
of	NULL
protein	NULL
kinases	NULL
or	NULL
phosphatases	NULL
.	NULL
``	NULL

To	NULL
study	NULL
in	NULL
detail	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
regulate	NULL
the	NULL
IL-2	NULL
production	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
stimulated	NULL
these	NULL
cells	NULL
either	NULL
polyclonally	NULL
,	NULL
using	NULL
the	NULL
phorbol	NULL
ester	NULL
and	NULL
calcium	NULL
ionophore	NULL
(	NULL
PDBu+iono	NULL
)	NULL
combination	NULL
,	NULL
which	NULL
bypasses	NULL
the	NULL
cell	NULL
surface	NULL
receptors	NULL
,	NULL
or	NULL
'physiologically	NULL
'	NULL
using	NULL
anti-CD3	NULL
+anti-CD28	NULL
stimulation	NULL
.	NULL

The	NULL
data	NULL
obtained	NULL
demonstrated	NULL
that	NULL
after	NULL
PDBu	NULL
+iono	NULL
stimulation	NULL
,	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
produced	NULL
equally	NULL
high	NULL
levels	NULL
of	NULL
IL-2	NULL
but	NULL
,	NULL
after	NULL
anti-CD3	NULL
+anti-CD28	NULL
stimulation	NULL
,	NULL
IL-2	NULL
levels	NULL
were	NULL
much	NULL
lower	NULL
in	NULL
neonatal	NULL
T-cell	NULL
cultures	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
signalling	NULL
mechanisms	NULL
indicated	NULL
that	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
anti-CD3	NULL
+	NULL
anti-CD28	NULL
stimulation	NULL
induced	NULL
a	NULL
weaker	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
and	NULL
lower	NULL
levels	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
than	NULL
in	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
OKT3	NULL
(	NULL
anti-CD3	NULL
)	NULL
antibody-containing	NULL
ascites	NULL
fluid	NULL
was	NULL
provided	NULL
by	NULL
Dr	NULL
M.	NULL
Kaartinen	NULL
(	NULL
Department	NULL
of	NULL
Bacteriology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Helsinki	NULL
,	NULL
Helsinki	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
OKT3	NULL
(	NULL
anti-CD3	NULL
mAb	NULL
)	NULL
from	NULL
Pharmingen	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
also	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
1	NULL
ug/ml	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
of	NULL
the	NULL
mouse	NULL
subclass	NULL
immunoglobulin	NULL
G1	NULL
(	NULL
IgG1	NULL
)	NULL
against	NULL
human	NULL
CD28	NULL
(	NULL
clone	NULL
CLB-CD28/1	NULL
15E8	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
the	NULL
Central	NULL
Laboratory	NULL
of	NULL
the	NULL
Netherlands	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
service	NULL
(	NULL
CLB	NULL
,	NULL
Amsterdam	NULL
,	NULL
the	NULL
Netherlands	NULL
)	NULL
.	NULL

Phorbol	NULL
dibutyrate	NULL
(	NULL
PDBu	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
(	NULL
A23187	NULL
)	NULL
was	NULL
from	NULL
Calbiochem	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
controlled	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
the	NULL
following	NULL
antibody	NULL
conjugates	NULL
were	NULL
used	NULL
:	NULL
IgG1-fluorescein	NULL
isothiocyan-ate	NULL
(	NULL
FITC	NULL
)	NULL
and	NULL
IgG2a-phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
as	NULL
isotype	NULL
controls	NULL
and	NULL
Leucogate	NULL
(	NULL
CD45/CD14	NULL
)	NULL
(	NULL
Becton-Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
culture	NULL
medium	NULL
consisted	NULL
of	NULL
RPMI-1640	NULL
(	NULL
Gibco	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
Gibco	NULL
)	NULL
,	NULL
10	NULL
mm	NULL
Hepes	NULL
buffer	NULL
,	NULL
2	NULL
mm	NULL
L-gluta-mine	NULL
and	NULL
antibiotics	NULL
(	NULL
complete	NULL
medium	NULL
)	NULL
.	NULL

Cell	NULL
preparation	NULL
Cord	NULL
blood	NULL
was	NULL
collected	NULL
from	NULL
the	NULL
umbilical	NULL
veins	NULL
of	NULL
healthy	NULL
,	NULL
full-term	NULL
newborns	NULL
after	NULL
normal	NULL
vaginal	NULL
delivery	NULL
(	NULL
kindly	NULL
performed	NULL
by	NULL
the	NULL
staff	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Obstetrics	NULL
,	NULL
Tampere	NULL
University	NULL
Hospital	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

Leucocyte-rich	NULL
buffy	NULL
coats	NULL
were	NULL
obtained	NULL
from	NULL
healthy	NULL
adult	NULL
blood	NULL
donors	NULL
(	NULL
Finnish	NULL
Red	NULL
Cross	NULL
Blood	NULL
Transfusion	NULL
Service	NULL
,	NULL
Tampere	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Isopaque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
centrifugation	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
most	NULL
of	NULL
the	NULL
adherent	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
plastic	NULL
plate	NULL
adherence	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
enriched	NULL
by	NULL
rosetting	NULL
with	NULL
S-	NULL
(	NULL
2-aminoethyl	NULL
)	NULL
isothiouroniumbromide-treated	NULL
_	NULL
sheep	NULL
_	NULL
red	NULL
blood	NULL
cells	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
petri	NULL
dishes	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10°	NULL
cells/ml	NULL
in	NULL
complete	NULL
medium	NULL
and	NULL
stimulated	NULL
.	NULL

IL-2	NULL
production	NULL
Microtitre	NULL
wells	NULL
were	NULL
coated	NULL
with	NULL
a	NULL
pretested	NULL
optimal	NULL
dilution	NULL
of	NULL
anti-CD3	NULL
antibody-containing	NULL
ascites	NULL
fluid	NULL
.	NULL

The	NULL
wells	NULL
were	NULL
incubated	NULL
at	NULL
37°	NULL
for	NULL
1	NULL
hr	NULL
and	NULL
then	NULL
washed	NULL
once	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
before	NULL
Tcells	NULL
were	NULL
added	NULL
(	NULL
250	NULL
x	NULL
103/well	NULL
)	NULL
.	NULL

Anti-CD28	NULL
mAb	NULL
,	NULL
PDBu	NULL
and	NULL
calcium	NULL
ionophore	NULL
were	NULL
added	NULL
directly	NULL
to	NULL
the	NULL
wells	NULL
.	NULL

Anti-CD28	NULL
mAb	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
2	NULL
ug/ml	NULL
;	NULL
PDBu	NULL
and	NULL
calcium	NULL
ionophore	NULL
were	NULL
used	NULL
at	NULL
final	NULL
concentrations	NULL
of	NULL
100	NULL
ng/ml	NULL
.	NULL

After	NULL
24	NULL
hr	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
stored	NULL
at	NULL
-20°	NULL
.	NULL

IL-2	NULL
levels	NULL
were	NULL
measured	NULL
using	NULL
an	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
;	NULL
Duoset	NULL
,	NULL
Genzyme	NULL
Diagnostics	NULL
,	NULL
Cambridge	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
the	NULL
assay	NULL
was	NULL
15:6	NULL
pg/ml	NULL
.	NULL

Measurement	NULL
of	NULL
intracellular	NULL
ROI	NULL
2	NULL
``	NULL
7-Dichlorofluorescin	NULL
diacetate	NULL
(	NULL
DCFH-DA	NULL
)	NULL
(	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
is	NULL
a	NULL
stable	NULL
non-fluorescent	NULL
cell-diffusible	NULL
dye	NULL
,	NULL
which	NULL
has	NULL
been	NULL
used	NULL
as	NULL
indicator	NULL
for	NULL
the	NULL
intracellular	NULL
formation	NULL
of	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
free	NULL
radicals	NULL
.	NULL
``	NULL

Intracellular	NULL
esterases	NULL
cleave	NULL
the	NULL
acetyl	NULL
groups	NULL
from	NULL
the	NULL
molecule	NULL
to	NULL
produce	NULL
non-fluorescent	NULL
2	NULL
'	NULL
7'-dichlorofluorescin	NULL
.	NULL

This	NULL
is	NULL
trapped	NULL
inside	NULL
the	NULL
cell	NULL
and	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ROI	NULL
,	NULL
27-dichlorofluorescin	NULL
is	NULL
further	NULL
modified	NULL
to	NULL
fluorescent	NULL
27-dichlorofluorescin	NULL
,	NULL
which	NULL
can	NULL
be	NULL
detected	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cells	NULL
were	NULL
preloaded	NULL
with	NULL
5	NULL
um	NULL
DCFH-DA	NULL
at	NULL
37°	NULL
for	NULL
15	NULL
min	NULL
in	NULL
PBS	NULL
and	NULL
were	NULL
then	NULL
stimulated	NULL
using	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
,	NULL
anti-CD28	NULL
mAb	NULL
or	NULL
PDBu	NULL
the	NULL
stimulator	NULL
concentrations	NULL
used	NULL
are	NULL
listed	NULL
above	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
performed	NULL
as	NULL
described'®	NULL
and	NULL
10000	NULL
individual	NULL
data	NULL
points	NULL
were	NULL
collected	NULL
for	NULL
each	NULL
sample	NULL
with	NULL
a	NULL
Becton-Dickinson	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
.	NULL

The	NULL
data	NULL
were	NULL
expressed	NULL
as	NULL
mean	NULL
level	NULL
of	NULL
fluorescence	NULL
(	NULL
FL1	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
fluorescence	NULL
of	NULL
unstimulated	NULL
samples	NULL
was	NULL
subtracted	NULL
from	NULL
that	NULL
of	NULL
stimulated	NULL
samples	NULL
at	NULL
each	NULL
time	NULL
point	NULL
.	NULL

Electrophoretic	NULL
mobility-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
The	NULL
NF-	NULL
«	NULL
xB	NULL
oligonucleotide	NULL
used	NULL
(	NULL
5-AGT	NULL
TGA	NULL
GGG	NULL
GAC	NULL
TTT	NULL
CCC	NULL
AGG	NULL
C-3	NULL
'	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

To	NULL
measure	NULL
the	NULL
association	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
xB	NULL
sequence	NULL
,	NULL
the	NULL
double-stranded	NULL
oligonucleotide	NULL
described	NULL
above	NULL
was	NULL
end-labelled	NULL
with	NULL
**P.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
10x	NULL
10°	NULL
cells	NULL
and	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

Nuclear	NULL
protein-DNA-binding	NULL
reactions	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
20	NULL
ul	NULL
containing	NULL
5	NULL
ug	NULL
nuclear	NULL
extract	NULL
protein	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7-5	NULL
)	NULL
,	NULL
40	NULL
mm	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
1	NULL
mm	NULL
dithio-threitol	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
mg	NULL
poly	NULL
dI-dC	NULL
(	NULL
Pharmacia	NULL
)	NULL
as	NULL
a	NULL
non-specific	NULL
competitor	NULL
and	NULL
10	NULL
fmol	NULL
5'-labelled	NULL
double-stranded	NULL
oligonucleotide	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Samples	NULL
were	NULL
then	NULL
analysed	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
94	NULL
,	NULL
167-172	NULL
Correlation	NULL
of	NULL
CD3	NULL
+	NULL
CD28-induced	NULL
IL-2	NULL
production	NULL
with	NULL
ROI	NULL
169	NULL
by	NULL
electrophoresis	NULL
on	NULL
4	NULL
%	NULL
non-denaturing	NULL
low-ionic-strength	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0-25	NULL
x	NULL
TBE	NULL
(	NULL
22	NULL
mm	NULL
Tris	NULL
,	NULL
22	NULL
mm	NULL
boric	NULL
acid	NULL
,	NULL
0:5	NULL
mm	NULL
EDTA	NULL
)	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

Autoradiograms	NULL
-	NULL
were	NULL
quantified	NULL
using	NULL
a	NULL
-	NULL
Personal	NULL
Densitometer	NULL
SI	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
Inc.	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Statistical	NULL
analysis	NULL
Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
for	NULL
independent	NULL
samples	NULL
.	NULL

RESULTS	NULL
Effect	NULL
of	NULL
anti-CD3	NULL
+	NULL
anti-CD2	NULL
$	NULL
8	NULL
stimulation	NULL
on	NULL
IL-2	NULL
production	NULL
When	NULL
stimulated	NULL
with	NULL
plate-bound	NULL
anti-CD3	NULL
mAb	NULL
,	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
was	NULL
undetectable	NULL
and	NULL
,	NULL
although	NULL
adult	NULL
T	NULL
cells	NULL
produced	NULL
only	NULL
low	NULL
amounts	NULL
of	NULL
IL-2	NULL
(	NULL
mean	NULL
331	NULL
+86	NULL
pg/ml	NULL
)	NULL
,	NULL
their	NULL
IL-2	NULL
secretion	NULL
was	NULL
significantly	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
well	NULL
documented	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
activated	NULL
via	NULL
their	NULL
CD3/TCR	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
causes	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
IL-2	NULL
mRNA	NULL
level	NULL
and	NULL
of	NULL
IL-2	NULL
secretion	NULL
.	NULL
``	NULL

Stimulation	NULL
of	NULL
cells	NULL
with	NULL
anti-CD3+anti-CD28	NULL
mAb	NULL
increased	NULL
IL-2	NULL
production	NULL
compared	NULL
to	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
mAb	NULL
alone	NULL
.	NULL

After	NULL
anti-CD3+anti-CD28	NULL
stimulation	NULL
,	NULL
IL-2	NULL
secretion	NULL
by	NULL
adult	NULL
cells	NULL
(	NULL
mean	NULL
4494	NULL
+1199	NULL
pg/ml	NULL
)	NULL
was	NULL
significantly	NULL
greater	NULL
than	NULL
IL-2	NULL
secretion	NULL
by	NULL
neonatal	NULL
cells	NULL
(	NULL
385	NULL
+109	NULL
pg/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Anti-CD28	NULL
mAb	NULL
was	NULL
normally	NULL
used	NULL
at	NULL
2	NULL
ug/ml	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
anti-CD28	NULL
mAb	NULL
was	NULL
added	NULL
in	NULL
graded	NULL
amounts	NULL
;	NULL
the	NULL
co-stimulatory	NULL
effect	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
on	NULL
IL-2	NULL
production	NULL
remained	NULL
the	NULL
same	NULL
at	NULL
concentrations	NULL
of	NULL
20	NULL
ug/ml	NULL
to	NULL
0-7	NULL
ug/ml	NULL
.	NULL

When	NULL
anti-CD28	NULL
mAb	NULL
was	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
0:2	NULL
ug/ml	NULL
,	NULL
it	NULL
no	NULL
longer	NULL
had	NULL
any	NULL
co-stimulatory	NULL
effect	NULL
on	NULL
IL-2	NULL
secretion	NULL
.	NULL

PDBu	NULL
was	NULL
a	NULL
potent	NULL
stimulator	NULL
of	NULL
IL-2	NULL
production	NULL
and	NULL
induced	NULL
a	NULL
similar	NULL
level	NULL
of	NULL
IL-2	NULL
production	NULL
in	NULL
neonatal	NULL
(	NULL
mean	NULL
157-6+300ng/ml	NULL
)	NULL
and	NULL
adult	NULL
(	NULL
mean	NULL
135-3	NULL
+17-5	NULL
ng/ml	NULL
)	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

With	NULL
this	NULL
activator	NULL
there	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
between	NULL
the	NULL
groups	NULL
.	NULL

Unstimulated	NULL
6000	NULL
[	NULL
Q	NULL
Adult	NULL
T	NULL
cells	NULL
®	NULL
Neonatal	NULL
T	NULL
cells	NULL
~	NULL
5000	NULL
}	NULL
E	NULL
&	NULL
&	NULL
4000	NULL
}	NULL
|=	NULL
9	NULL
5	NULL
3000	NULL
|	NULL
&	NULL
©	NULL
o	NULL
5	NULL
2000	NULL
}	NULL
O	NULL
Y	NULL
=	NULL
1000	NULL
}	NULL
0	NULL
Anti-CD3	NULL
Anti-CD3+anti-CD28	NULL
Figure	NULL
1	NULL
.	NULL

IL-2	NULL
production	NULL
by	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
mAb	NULL
and	NULL
anti-CD3	NULL
+anti-CD28	NULL
mAb	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
24	NULL
hr	NULL
after	NULL
stimulation	NULL
and	NULL
IL-2	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
the	NULL
assay	NULL
was	NULL
15-6	NULL
pg/ml	NULL
.	NULL

These	NULL
results	NULL
are	NULL
the	NULL
mean	NULL
values	NULL
+	NULL
standard	NULL
error	NULL
of	NULL
10	NULL
separate	NULL
experiments	NULL
.	NULL

*P	NULL
<	NULL
0-002	NULL
for	NULL
anti-CD3-stimulated	NULL
cells	NULL
and	NULL
P	NULL
<	NULL
0-004	NULL
for	NULL
anti-CD3	NULL
+	NULL
anti-CD28-stimulated	NULL
cells	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
94	NULL
,	NULL
167-172	NULL
200000	NULL
r	NULL
q	NULL
Adult	NULL
T	NULL
cells	NULL
I	NULL
Neonatal	NULL
T	NULL
cells	NULL
100000	NULL
t	NULL
IL-2	NULL
concentration	NULL
(	NULL
pg/ml	NULL
!	NULL
)	NULL

PDBu+iono	NULL
Figure	NULL
2	NULL
.	NULL

IL-2	NULL
production	NULL
by	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
PDBu	NULL
Supernatants	NULL
were	NULL
harvested	NULL
24	NULL
hr	NULL
after	NULL
stimulation	NULL
and	NULL
IL-2	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
ELISA	NULL
.	NULL

The	NULL
sensitivity	NULL
of	NULL
the	NULL
assay	NULL
was	NULL
156	NULL
pg/ml	NULL
.	NULL

These	NULL
results	NULL
are	NULL
the	NULL
mean	NULL
values	NULL
+standard	NULL
error	NULL
of	NULL
10	NULL
separate	NULL
experiments	NULL
.	NULL

No	NULL
significant	NULL
difference	NULL
was	NULL
found	NULL
between	NULL
the	NULL
two	NULL
groups	NULL
.	NULL

cells	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
alone	NULL
showed	NULL
no	NULL
IL-2	NULL
production	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD3	NULL
+	NULL
anti-CD28	NULL
stimulation	NULL
on	NULL
NF-xB	NULL
activation	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
ubiquitously	NULL
expressed	NULL
transcription	NULL
factor	NULL
that	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

*	NULL
'	NULL
Previous	NULL
reports	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IL-2	NULL
gene	NULL
promoter	NULL
has	NULL
a	NULL
CD28-responsive	NULL
element	NULL
(	NULL
CD28RE	NULL
)	NULL
*	NULL
and	NULL
,	NULL
after	NULL
CD28	NULL
co-stimulation	NULL
,	NULL
this	NULL
region	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL
``	NULL

''	NULL
Based	NULL
on	NULL
these	NULL
results	NULL
,	NULL
levels	NULL
of	NULL
NF-KB	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
+	NULL
anti-CD28	NULL
mAb	NULL
for	NULL
24	NULL
hr	NULL
were	NULL
examined	NULL
.	NULL

Fig	NULL
.	NULL

3	NULL
shows	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NF-xB	NULL
using	NULL
the	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
anti-CD28	NULL
mAb	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
showed	NULL
no	NULL
or	NULL
low	NULL
levels	NULL
of	NULL
NF-xB	NULL
.	NULL

Anti-CD3	NULL
stimulation	NULL
induced	NULL
an	NULL
increase	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
activation	NULL
,	NULL
which	NULL
was	NULL
greatly	NULL
enhanced	NULL
when	NULL
anti-CD28	NULL
mAb	NULL
was	NULL
added	NULL
as	NULL
a	NULL
co-stimulus	NULL
to	NULL
the	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
NF-xB	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
stimulation	NULL
was	NULL
low	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
lane	NULL
5	NULL
versus	NULL
lane	NULL
2	NULL
,	NULL
respective	NULL
densitometric	NULL
values	NULL
7	NULL
and	NULL
1160	NULL
)	NULL
.	NULL

Although	NULL
addition	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
to	NULL
neonatal	NULL
cells	NULL
increased	NULL
NF-KB	NULL
levels	NULL
,	NULL
they	NULL
were	NULL
not	NULL
restored	NULL
to	NULL
the	NULL
levels	NULL
observed	NULL
in	NULL
adults	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
6	NULL
versus	NULL
lane	NULL
3	NULL
,	NULL
respective	NULL
densitometric	NULL
values	NULL
894	NULL
and	NULL
2039	NULL
)	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD3	NULL
+	NULL
anti-CD28	NULL
stimulation	NULL
on	NULL
ROI	NULL
formation	NULL
It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
co-stimulatory	NULL
CD28	NULL
pathway	NULL
leads	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
ROI	NULL
``	NULL
and	NULL
that	NULL
ROI	NULL
are	NULL
important	NULL
regulators	NULL
of	NULL
NF-xB	NULL
activation	NULL
.	NULL
``	NULL

In	NULL
both	NULL
groups	NULL
,	NULL
anti-CD3	NULL
+anti-CD28	NULL
stimulation	NULL
clearly	NULL
induced	NULL
stronger	NULL
ROI	NULL
production	NULL
than	NULL
anti-CD3	NULL
stimulation	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
adult	NULL
cells	NULL
always	NULL
produced	NULL
higher	NULL
levels	NULL
of	NULL
ROI	NULL
than	NULL
neonatal	NULL
cells	NULL
,	NULL
both	NULL
with	NULL
anti-CD3	NULL
and	NULL
with	NULL
anti-CD3	NULL
+anti-CD28	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
PDBu+iono	NULL
induced	NULL
rapid	NULL
and	NULL
powerful	NULL
ROI	NULL
formation	NULL
,	NULL
170	NULL
S.	NULL
Kilpinen	NULL
&	NULL
M.	NULL
Hurme	NULL
NF-	NULL
«	NULL
B	NULL
-=	NULL
Adult	NULL
Cord	NULL
Figure	NULL
3	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
on	NULL
nuclear	NULL
NF-KB	NULL
levels	NULL
in	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
unstimulated	NULL
,	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
or	NULL
anti-CD3+anti-CD28	NULL
mAb	NULL
for	NULL
24	NULL
hr	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
NF-xB	NULL
DNA-binding	NULL
activity	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
specific	NULL
DNA-protein	NULL
complexes	NULL
are	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

500	NULL
r	NULL
-o-	NULL
CD3/adult	NULL
T	NULL
cells	NULL
-=-	NULL
CD3/cord	NULL
T	NULL
cells	NULL
o	NULL
adult	NULL
T	NULL
cells	NULL
2	NULL
-*-	NULL
CD3+CD28/	NULL
8	NULL
300	NULL
}	NULL
cord	NULL
T	NULL
cells	NULL
,	NULL
*	NULL
3	NULL
0	NULL
3	NULL
``	NULL
=	NULL
200	NULL
;	NULL
a	NULL
@	NULL
bs	NULL
100	NULL
[	NULL
15	NULL
30	NULL
45	NULL
60	NULL
75	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
on	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
in	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

Purified	NULL
cells	NULL
were	NULL
preloaded	NULL
with	NULL
5	NULL
um	NULL
dichlorofluorescein	NULL
diacetate	NULL
(	NULL
DCFH-DA	NULL
)	NULL
and	NULL
stimulated	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
the	NULL
cells	NULL
were	NULL
analysed	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
the	NULL
mean	NULL
level	NULL
of	NULL
fluorescence	NULL
(	NULL
FL1	NULL
)	NULL
was	NULL
calculated	NULL
.	NULL

At	NULL
each	NULL
time	NULL
point	NULL
the	NULL
unstimulated	NULL
controls	NULL
were	NULL
also	NULL
measured	NULL
and	NULL
these	NULL
fluorescence	NULL
levels	NULL
were	NULL
subtracted	NULL
from	NULL
fluorescence	NULL
levels	NULL
of	NULL
stimulated	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

which	NULL
was	NULL
equally	NULL
high	NULL
in	NULL
both	NULL
cell	NULL
populations	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

As	NULL
it	NULL
was	NULL
previously	NULL
observed	NULL
that	NULL
ligation	NULL
of	NULL
CD28	NULL
causes	NULL
the	NULL
rapid	NULL
decrease	NULL
of	NULL
glutathione	NULL
within	NULL
minutes	NULL
and	NULL
increases	NULL
ROI	NULL
formation	NULL
,	NULL
which	NULL
is	NULL
maintained	NULL
for	NULL
16-24	NULL
hr	NULL
after	NULL
stimula-tion	NULL
,	NULL
``	NULL
``	NULL
it	NULL
was	NULL
surprising	NULL
in	NULL
our	NULL
experiments	NULL
that	NULL
the	NULL
ROI	NULL
levels	NULL
started	NULL
to	NULL
decrease	NULL
so	NULL
soon	NULL
after	NULL
cell	NULL
stimulation	NULL
(	NULL
Figs	NULL
900	NULL
{	NULL
-a-	NULL
PDBu+iono/adult	NULL
T	NULL
cells	NULL
soo	NULL
}	NULL
-*-	NULL
PDBu+iono/cord	NULL
T	NULL
cells	NULL
700	NULL
|	NULL
600	NULL
}	NULL
500	NULL
}	NULL
400	NULL
F	NULL
Mean	NULL
fluorescence	NULL
300	NULL
f	NULL
200	NULL
|	NULL
100	NULL
F	NULL
0	NULL
T	NULL
T	NULL
u	NULL
t	NULL
T	NULL
15	NULL
30	NULL
45	NULL
60	NULL
75	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
Figure	NULL
5	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
PDB+iono	NULL
on	NULL
the	NULL
intracellular	NULL
levels	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROI	NULL
)	NULL
in	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

This	NULL
phenomenon	NULL
may	NULL
partly	NULL
result	NULL
from	NULL
properties	NULL
of	NULL
2',7'-dichlorofluorescindiacetate	NULL
(	NULL
DCF-DA	NULL
)	NULL
.	NULL

Intracellular	NULL
oxidation	NULL
of	NULL
DCF-DA	NULL
tends	NULL
to	NULL
be	NULL
accompanied	NULL
by	NULL
leakage	NULL
of	NULL
the	NULL
end	NULL
product	NULL
(	NULL
2',7'-dichlorofluorescein	NULL
)	NULL
from	NULL
the	NULL
cell	NULL
,	NULL
which	NULL
may	NULL
make	NULL
detection	NULL
of	NULL
slow	NULL
oxidation	NULL
difficult	NULL
.	NULL
``	NULL

''	NULL
DISCUSSION	NULL
Previous	NULL
studies	NULL
have	NULL
observed	NULL
a	NULL
reduced	NULL
IL-2	NULL
production	NULL
and	NULL
proliferation	NULL
after	NULL
anti-CD3	NULL
stimulation	NULL
in	NULL
murine	NULL
neonatal	NULL
T	NULL
cells*	NULL
and	NULL
our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
these	NULL
studies	NULL
.	NULL

It	NULL
has	NULL
also	NULL
been	NULL
found	NULL
previously	NULL
that	NULL
anti-CD3-stimulated	NULL
neonatal	NULL
T	NULL
cells	NULL
of	NULL
mice	NULL
greatly	NULL
increased	NULL
their	NULL
IL-2	NULL
production	NULL
in	NULL
response	NULL
to	NULL
anti-CD28	NULL
mAb	NULL
``	NULL
and	NULL
we	NULL
noted	NULL
the	NULL
same	NULL
phenomenon	NULL
in	NULL
human	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
data	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
decreased	NULL
IL-2	NULL
secretion	NULL
of	NULL
neonatal	NULL
cells	NULL
is	NULL
specific	NULL
for	NULL
CD3	NULL
and	NULL
CD3	NULL
+CD28-mediated	NULL
stimulation	NULL
;	NULL
direct	NULL
stimulation	NULL
with	NULL
PDBu+iono	NULL
induced	NULL
equally	NULL
high	NULL
IL-2	NULL
levels	NULL
.	NULL

The	NULL
lower	NULL
reactivity	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
could	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
different	NULL
expression	NULL
of	NULL
these	NULL
surface	NULL
molecules	NULL
on	NULL
the	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
the	NULL
surface	NULL
expression	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
to	NULL
be	NULL
similar	NULL
both	NULL
in	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
:	NULL
98	NULL
%	NULL
CD3	NULL
in	NULL
adults	NULL
,	NULL
98	NULL
%	NULL
CD3	NULL
in	NULL
newborns	NULL
;	NULL
and	NULL
74	NULL
%	NULL
CD28	NULL
in	NULL
adults	NULL
,	NULL
77	NULL
%	NULL
CD28	NULL
in	NULL
newborns	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
thus	NULL
being	NULL
consistent	NULL
with	NULL
previous	NULL
reports	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
To	NULL
clarify	NULL
the	NULL
molecular	NULL
background	NULL
of	NULL
reduced	NULL
IL-2	NULL
secretion	NULL
by	NULL
neonates	NULL
after	NULL
receptor-mediated	NULL
stimulation	NULL
we	NULL
analysed	NULL
activation	NULL
of	NULL
NF-xB	NULL
and	NULL
ROI	NULL
formation	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
important	NULL
inducible	NULL
regulator	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
and	NULL
several	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
ROI	NULL
are	NULL
a	NULL
common	NULL
messenger	NULL
required	NULL
for	NULL
NF-xB	NULL
activation	NULL
,	NULL
although	NULL
the	NULL
exact	NULL
activation	NULL
mechanism	NULL
is	NULL
still	NULL
unknown	NULL
.	NULL

**	NULL
We	NULL
observed	NULL
that	NULL
NF-xB	NULL
activation	NULL
and	NULL
ROI	NULL
formation	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
parallel	NULL
with	NULL
their	NULL
IL-2	NULL
production	NULL
.	NULL

In	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
NF-xB	NULL
activation	NULL
and	NULL
ROI	NULL
formation	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
stimulation	NULL
were	NULL
low	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
although	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
94	NULL
,	NULL
167-172	NULL
Correlation	NULL
of	NULL
CD3	NULL
+	NULL
CD28-induced	NULL
IL-2	NULL
production	NULL
with	NULL
ROI	NULL
171	NULL
addition	NULL
of	NULL
anti-CD28	NULL
mAb	NULL
increased	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
ROI	NULL
formation	NULL
,	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
adults	NULL
were	NULL
not	NULL
achieved	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
PDBu+iono	NULL
,	NULL
cells	NULL
showed	NULL
similar	NULL
ROI	NULL
formation	NULL
and	NULL
IL-2	NULL
secretion	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
cord	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
24	NULL
hr	NULL
with	NULL
PDBu+iono	NULL
had	NULL
even	NULL
stronger	NULL
NF-xB	NULL
activation	NULL
than	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

It	NULL
is	NULL
well	NULL
known	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
not	NULL
the	NULL
only	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
IL-2	NULL
production	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

Transcription	NULL
factors	NULL
such	NULL
as	NULL
NF-AT	NULL
,	NULL
AP-1	NULL
,	NULL
Oct-1	NULL
and	NULL
AP-3	NULL
also	NULL
regulate	NULL
IL-2	NULL
transcription	NULL
,	NULL
and	NULL
the	NULL
co-operation	NULL
of	NULL
these	NULL
factors	NULL
is	NULL
required	NULL
for	NULL
complete	NULL
T-cell	NULL
activation	NULL
.	NULL
``	NULL

'	NULL
Based	NULL
on	NULL
present	NULL
data	NULL
,	NULL
two	NULL
of	NULL
these	NULL
factors	NULL
-	NULL
AP-1	NULL
and	NULL
NF-xB	NULL
-	NULL
are	NULL
regulated	NULL
by	NULL
the	NULL
intracellular	NULL
redox	NULL
state	NULL
.	NULL
``	NULL

''	NULL
As	NULL
oxidative	NULL
stress	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
perturb	NULL
intracellular	NULL
Ca**	NULL
homeostasis	NULL
,	NULL
``	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
ROI	NULL
may	NULL
modify	NULL
more	NULL
than	NULL
just	NULL
these	NULL
two	NULL
transcription	NULL
factors	NULL
.	NULL

In	NULL
our	NULL
present	NULL
study	NULL
we	NULL
concentrated	NULL
on	NULL
transcription	NULL
factor	NULL
NF-xB	NULL
,	NULL
because	NULL
it	NULL
is	NULL
an	NULL
oxidative	NULL
stress-responsive	NULL
factor	NULL
and	NULL
previous	NULL
data	NULL
have	NULL
shown	NULL
that	NULL
signalling	NULL
through	NULL
CD28	NULL
increased	NULL
NF-xB	NULL
activation	NULL
but	NULL
significantly	NULL
inhibited	NULL
AP-1	NULL
activation	NULL
.	NULL
``	NULL

We	NULL
found	NULL
decreased	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
after	NULL
anti-CD3	NULL
and	NULL
anti-CD3	NULL
+anti-CD28	NULL
stimulation	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
some	NULL
other	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
IL-2	NULL
transcription	NULL
after	NULL
this	NULL
stimulation	NULL
would	NULL
also	NULL
be	NULL
decreased	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Our	NULL
present	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
reduced	NULL
IL-2	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
could	NULL
result	NULL
from	NULL
decreased	NULL
ROI	NULL
formation	NULL
after	NULL
anti-CD3	NULL
and	NULL
anti-CD3+anti-CD28	NULL
stimulation	NULL
.	NULL

ROI	NULL
can	NULL
act	NULL
as	NULL
signal	NULL
transducers	NULL
by	NULL
modifying	NULL
,	NULL
directly	NULL
or	NULL
indirectly	NULL
,	NULL
different	NULL
protein	NULL
kinases	NULL
or	NULL
phosphatases	NULL
,	NULL
which	NULL
then	NULL
activate	NULL
NF-xB	NULL
.	NULL

``	NULL
°	NULL
Reduced	NULL
levels	NULL
of	NULL
ROI	NULL
formation	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
was	NULL
specific	NULL
for	NULL
stimulation	NULL
via	NULL
CD3	NULL
and	NULL
CD28	NULL
receptors	NULL
.	NULL

It	NULL
has	NULL
been	NULL
observed	NULL
that	NULL
the	NULL
activity	NULL
and	NULL
expression	NULL
of	NULL
p56	NULL
``	NULL
*	NULL
and	NULL
p59	NULL
``	NULL
,	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
of	NULL
the	NULL
Src	NULL
family	NULL
,	NULL
are	NULL
lower	NULL
in	NULL
cord	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
The	NULL
function	NULL
of	NULL
these	NULL
kinases	NULL
is	NULL
essential	NULL
for	NULL
efficient	NULL
signalling	NULL
through	NULL
TCR	NULL
,	NULL
``	NULL
and	NULL
it	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
p56	NULL
``	NULL
and/or	NULL
p59°	NULL
``	NULL
could	NULL
also	NULL
participate	NULL
in	NULL
signalling	NULL
through	NULL
the	NULL
CD28	NULL
molecule	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
37	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
have	NULL
been	NULL
found	NULL
to	NULL
be	NULL
redox	NULL
sensitive	NULL
.	NULL
``	NULL

''	NULL
Thus	NULL
,	NULL
it	NULL
may	NULL
be	NULL
hypothesized	NULL
that	NULL
the	NULL
reduced	NULL
activity	NULL
and	NULL
expression	NULL
of	NULL
these	NULL
kinases	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
could	NULL
account	NULL
for	NULL
the	NULL
reduced	NULL
ROI	NULL
formation	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
observed	NULL
after	NULL
anti-CD3	NULL
and	NULL
anti-CD3	NULL
+	NULL
anti-CD28	NULL
stimulation	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
reduced	NULL
IL-2	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
result	NULL
of	NULL
decreased	NULL
ROI	NULL
formation	NULL
,	NULL
and	NULL
thus	NULL
decreased	NULL
NF-xB	NULL
activation	NULL
.	NULL

Neonatal	NULL
T	NULL
cells	NULL
are	NULL
'true	NULL
'	NULL
naive	NULL
cells	NULL
,	NULL
which	NULL
have	NULL
not	NULL
previously	NULL
encountered	NULL
antigen	NULL
,	NULL
and	NULL
their	NULL
activation	NULL
leads	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
a	NULL
cell	NULL
cycle	NULL
from	NULL
a	NULL
'true	NULL
'	NULL
resting	NULL
state	NULL
.	NULL

Various	NULL
groups	NULL
have	NULL
shown	NULL
that	NULL
naive	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
higher	NULL
activation	NULL
threshold	NULL
for	NULL
the	NULL
CD3/TCR	NULL
signal	NULL
than	NULL
memory	NULL
T	NULL
cells	NULL
``	NULL
``	NULL
and	NULL
optimal	NULL
CD28	NULL
co-stimulation	NULL
can	NULL
not	NULL
compensate	NULL
for	NULL
this	NULL
difference	NULL
.	NULL
``	NULL

Together	NULL
with	NULL
these	NULL
earlier	NULL
reports	NULL
,	NULL
our	NULL
findings	NULL
suggest	NULL
that	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
have	NULL
,	NULL
at	NULL
least	NULL
partly	NULL
,	NULL
different	NULL
activation	NULL
requirements	NULL
and	NULL
intrinsic	NULL
properties	NULL
and	NULL
thus	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
neonatal	NULL
T	NULL
cells	NULL
are	NULL
at	NULL
a	NULL
different	NULL
stage	NULL
of	NULL
development	NULL
and	NULL
differentiation	NULL
.	NULL

Studies	NULL
even	NULL
exist	NULL
which	NULL
have	NULL
found	NULL
the	NULL
function	NULL
of	NULL
phenotypically	NULL
similar	NULL
,	NULL
CD4*CD4SRA	NULL
*	NULL
,	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
to	NULL
be	NULL
different	NULL
©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
94	NULL
,	NULL
167-172	NULL
and	NULL
which	NULL
suggest	NULL
that	NULL
the	NULL
neonatal	NULL
CD4*CD4SRA	NULL
*	NULL
T	NULL
cell	NULL
is	NULL
a	NULL
precursor	NULL
of	NULL
the	NULL
adult	NULL
CD4*CD4SRA	NULL
*	NULL
T	NULL
cell	NULL
.	NULL

***	NULL
``	NULL
Recent	NULL
studies	NULL
in	NULL
our	NULL
laboratory	NULL
support	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
functions	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
differ	NULL
from	NULL
those	NULL
of	NULL
adult	NULL
naive	NULL
T	NULL
cells	NULL
;	NULL
after	NULL
anti-CD3+anti-CD28	NULL
stimulation	NULL
CD4SRA*t	NULL
and	NULL
CD4S5RO	NULL
*	NULL
T	NULL
cells	NULL
of	NULL
adults	NULL
produced	NULL
equally	NULL
high	NULL
IL-2	NULL
levels	NULL
,	NULL
and	NULL
induction	NULL
of	NULL
NF-xB	NULL
activation	NULL
and	NULL
ROI	NULL
formation	NULL
were	NULL
stronger	NULL
in	NULL
naive	NULL
than	NULL
in	NULL
memory	NULL
T	NULL
cells	NULL
of	NULL
adults	NULL
.	NULL
``	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
The	NULL
Academy	NULL
of	NULL
Finland	NULL
and	NULL
from	NULL
the	NULL
Research	NULL
Fund	NULL
of	NULL
Tampere	NULL
University	NULL
Hospital	NULL
.	NULL

The	NULL
authors	NULL
would	NULL
like	NULL
to	NULL
thank	NULL
Mrs	NULL
Sinikka	NULL
Repo-Koskinen	NULL
and	NULL
Mrs	NULL
Mervi	NULL
Salomé	NULL
@	NULL
ki	NULL
for	NULL
expert	NULL
technical	NULL
assistance	NULL
and	NULL
the	NULL
staff	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Obstetrics	NULL
,	NULL
Tampere	NULL
University	NULL
Hospital	NULL
for	NULL
providing	NULL
the	NULL
cord	NULL
blood	NULL
samples	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Tepper	NULL
TF	NULL
.	NULL

,	NULL
CremeNt	NULL
LT.	NULL
&	NULL
Cooper	NULL
M.D	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Human	NULL
lymphocyte	NULL
differentiation	NULL
antigens	NULL
HB-10	NULL
and	NULL
HB-ll	NULL
.	NULL

I.	NULL
Ontogeny	NULL
of	NULL
antigen	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
134	NULL
,	NULL
2983	NULL
.	NULL

2	NULL
.	NULL

Bevertey	NULL
PCL	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Human	NULL
T-cell	NULL
memory	NULL
.	NULL

Curr	NULL
Top	NULL
Microbiol	NULL
Immunol	NULL
159	NULL
,	NULL
111	NULL
.	NULL

3	NULL
.	NULL

Armep	NULL
R.	NULL
&	NULL
Gray	NULL
D.	NULL
(	NULL
1996	NULL
)	NULL
Immunological	NULL
memory	NULL
and	NULL
protective	NULL
immunity	NULL
:	NULL
understanding	NULL
their	NULL
relation	NULL
.	NULL

Science	NULL
272	NULL
,	NULL
54	NULL
.	NULL

4	NULL
.	NULL

Lewis	NULL
D.B	NULL
.	NULL

,	NULL
Yu	NULL
C.C	NULL
.	NULL

,	NULL
Meyer	NULL
J.	NULL
,	NULL
Encusn	NULL
BK	NULL
.	NULL

,	NULL
Kann	NULL
SJ	NULL
.	NULL

&	NULL
Wirson	NULL
C.B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cellular	NULL
and	NULL
molecular	NULL
mechanisms	NULL
for	NULL
reduced	NULL
interleukin	NULL
4	NULL
and	NULL
interferon-y	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
87	NULL
,	NULL
194	NULL
.	NULL

5	NULL
.	NULL

Cunepa	NULL
S.	NULL
,	NULL
KH	NULL
.	NULL

,	NULL
Garorato	NULL
R.	NULL
,	NULL
Rassin	NULL
DK	NULL
.	NULL

&	NULL
Gorpman	NULL
A.S.	NULL
(	NULL
1996	NULL
)	NULL
Decreased	NULL
interleukin-10	NULL
production	NULL
by	NULL
neonatal	NULL
monocytes	NULL
and	NULL
T	NULL
cells	NULL
:	NULL
relationship	NULL
to	NULL
decreased	NULL
production	NULL
and	NULL
expression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
and	NULL
its	NULL
receptor	NULL
.	NULL

Pediatr	NULL
Res	NULL
40	NULL
,	NULL
475	NULL
.	NULL

6	NULL
.	NULL

Famrax	NULL
C.A	NULL
.	NULL

&	NULL
Borzy	NULL
M.S	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Interleukin	NULL
2	NULL
production	NULL
,	NULL
proliferative	NULL
response	NULL
and	NULL
receptor	NULL
expression	NULL
by	NULL
cord	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Lab	NULL
Immunol	NULL
27	NULL
,	NULL
63	NULL
.	NULL

7	NULL
.	NULL

Crerict	NULL
M.	NULL
,	NULL
DeParma	NULL
L.	NULL
,	NULL
Roms	NULL
E.	NULL
,	NULL
Baker	NULL
R.	NULL
&	NULL
SHEarer	NULL
G.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Analysis	NULL
of	NULL
T	NULL
helper	NULL
and	NULL
antigen-presenting	NULL
cell	NULL
functions	NULL
in	NULL
cord	NULL
blood	NULL
and	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
from	NULL
healthy	NULL
children	NULL
of	NULL
different	NULL
ages	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
91	NULL
,	NULL
2829	NULL
.	NULL

8	NULL
.	NULL

Hassan	NULL
J	NULL
.	NULL

&	NULL
Reen	NULL
D.J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Reduced	NULL
primary	NULL
antigen-specific	NULL
T	NULL
cell	NULL
precursor	NULL
frequencies	NULL
in	NULL
neonates	NULL
is	NULL
associated	NULL
with	NULL
deficient	NULL
interleukin-2	NULL
production	NULL
.	NULL

Immunology	NULL
87	NULL
,	NULL
604	NULL
.	NULL

9	NULL
.	NULL

Apkins	NULL
B	NULL
.	NULL

&	NULL
Hamitton	NULL
K.	NULL
(	NULL
1992	NULL
)	NULL
Freshly	NULL
isolated	NULL
,	NULL
murine	NULL
neonatal	NULL
T	NULL
cells	NULL
produce	NULL
IL-4	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
stimulation	NULL
.	NULL

J	NULL
Immunol	NULL
149	NULL
,	NULL
3448	NULL
.	NULL

10	NULL
.	NULL

Geru1	NULL
R.	NULL
,	NULL
Bertotto	NULL
A.	NULL
,	NULL
Crupi	NULL
S.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Activation	NULL
of	NULL
cord	NULL
T	NULL
lymphocytes	NULL
.	NULL

I	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
defective	NULL
T	NULL
cell	NULL
mitogenesis	NULL
induced	NULL
through	NULL
the	NULL
CD2	NULL
molecule	NULL
.	NULL

J	NULL
Immuno	NULL
!	NULL

142	NULL
,	NULL
2583	NULL
.	NULL

11	NULL
.	NULL

Urcman	NULL
K.S	NULL
.	NULL

,	NULL
NortHrop	NULL
J.P.	NULL
,	NULL
VerwEeu	NULL
C.L	NULL
.	NULL

&	NULL
CrastRree	NULL
G.R	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
lymphocyte	NULL
antigen	NULL
receptor	NULL
to	NULL
the	NULL
genes	NULL
responsible	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
immune	NULL
function	NULL
:	NULL
the	NULL
missing	NULL
link	NULL
.	NULL

Annu	NULL
Rev	NULL
Immuno	NULL
!	NULL

8	NULL
,	NULL
421	NULL
.	NULL

12	NULL
.	NULL

Unmraur	NULL
S.W	NULL
.	NULL

,	NULL
Beveriy	NULL
B.	NULL
,	NULL
Kanc	NULL
S.	NULL
,	NULL
Brorson	NULL
K.	NULL
,	NULL
Tran	NULL
A	NULL
.	NULL

&	NULL
ScHwartz	NULL
RH	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Molecular	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
:	NULL
rheostatic	NULL
control	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Immunol	NULL
Rev	NULL
133	NULL
,	NULL
177	NULL
.	NULL

13	NULL
.	NULL

GHosH	NULL
P.	NULL
,	NULL
Tan	NULL
T.	NULL
,	NULL
Rice	NULL
N.R	NULL
.	NULL

,	NULL
Sica	NULL
A	NULL
.	NULL

&	NULL
Young	NULL
HA	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
interleukin-2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF	NULL
xB	NULL
family	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Proc	NULL
Nail	NULL
Acad	NULL
Sci	NULL
USA	NULL
90	NULL
,	NULL
1696	NULL
.	NULL

14	NULL
.	NULL

Baeverte	NULL
P.A	NULL
.	NULL

&	NULL
Henket	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Function	NULL
and	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
12	NULL
,	NULL
141	NULL
.	NULL

172	NULL
15	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

Burpon	NULL
RH	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Superoxide	NULL
and	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
relation	NULL
to	NULL
mammalian	NULL
cell	NULL
proliferation	NULL
.	NULL

Free	NULL
Rad	NULL
Bio	NULL
!	NULL

Med	NULL
18	NULL
,	NULL
775.	NULL
.	NULL

Sen	NULL
CK	NULL
.	NULL

&	NULL
Packer	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Antioxidant	NULL
and	NULL
redox	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

FASEB	NULL
J	NULL
10	NULL
,	NULL
709.	NULL
.	NULL

Burow	NULL
S.	NULL
&	NULL
Varet	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Flow-cytometric	NULL
characterization	NULL
of	NULL
stimulation	NULL
,	NULL
free	NULL
radical	NULL
formation	NULL
,	NULL
peroxidase	NULL
activity	NULL
and	NULL
phagocytosis	NULL
of	NULL
human	NULL
granulocytes	NULL
with	NULL
2,7-dichlorofluorescein	NULL
(	NULL
DCF	NULL
)	NULL
.	NULL

Eur	NULL
J	NULL
Cell	NULL
Biol	NULL
43	NULL
,	NULL
128.	NULL
.	NULL

Vint	NULL
LA.M	NULL
.	NULL

,	NULL
Foreman	NULL
J.C.	NULL
&	NULL
CHam	NULL
B.M	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
gold	NULL
anti	NULL
rheumatic	NULL
drug	NULL
auranofin	NULL
governs	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
enhancing	NULL
oxygen	NULL
free	NULL
radical	NULL
production	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
24	NULL
,	NULL
1961	NULL
.	NULL

AnprEws	NULL
N.C.	NULL
&	NULL
Farrer	NULL
D.V	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
A	NULL
rapid	NULL
micropreparation	NULL
technique	NULL
for	NULL
extraction	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
limiting	NULL
numbers	NULL
of	NULL
mammalian	NULL
cells	NULL
.	NULL

Nuc	NULL
!	NULL

Acids	NULL
Res	NULL
19	NULL
,	NULL
249	NULL
.	NULL

TrHompson	NULL
C.B	NULL
.	NULL

,	NULL
LinpsteEN	NULL
T.	NULL
,	NULL
LepsEtTTER	NULL
J.A	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
CD28	NULL
activation	NULL
pathway	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
multiple	NULL
T-cell-derived	NULL
lymphokines/cytokines	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
USA	NULL
86	NULL
,	NULL
1333	NULL
.	NULL

BaALDwin	NULL
A.S.	NULL
(	NULL
1996	NULL
)	NULL
The	NULL
NF-xB	NULL
and	NULL
IxB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
14	NULL
,	NULL
649	NULL
.	NULL

Fraser	NULL
J.D	NULL
.	NULL

,	NULL
Irving	NULL
B.A	NULL
.	NULL

,	NULL
CrastreEE	NULL
G.R	NULL
.	NULL

&	NULL
Weiss	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Regulation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
251	NULL
,	NULL
313	NULL
.	NULL

Los	NULL
M.	NULL
,	NULL
Schenk	NULL
H.	NULL
,	NULL
Hexet	NULL
K.	NULL
,	NULL
PA.	NULL
,	NULL
Droor	NULL
W.	NULL
&	NULL
ScHurze-OstHorr	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
IL-2	NULL
gene	NULL
expression	NULL
and	NULL
NF-xB	NULL
activation	NULL
through	NULL
CD28	NULL
requires	NULL
reactive	NULL
oxygen	NULL
production	NULL
by	NULL
5-lipoxygenase	NULL
.	NULL

EMBO	NULL
J	NULL
14	NULL
,	NULL
3731	NULL
.	NULL

ScHurze-OstrHorr	NULL
K.	NULL
,	NULL
Los	NULL
M.	NULL
&	NULL
BasuEruE	NULL
PA.	NULL
(	NULL
1995	NULL
)	NULL
Redox	NULL
signalling	NULL
by	NULL
transcription	NULL
factors	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
in	NULL
lymphocytes	NULL
.	NULL

Biochem	NULL
Pharmacol	NULL
50	NULL
,	NULL
735	NULL
.	NULL

CostELLO	NULL
R.	NULL
,	NULL
Lipcey	NULL
C.	NULL
,	NULL
ArGaRTE	NULL
M.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Activation	NULL
of	NULL
primary	NULL
human	NULL
T-lymphocytes	NULL
through	NULL
CD2	NULL
plus	NULL
CD28	NULL
adhesion	NULL
molecules	NULL
induces	NULL
long-term	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-xB	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
4	NULL
,	NULL
329	NULL
.	NULL

RP	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Assaying	NULL
oxidative	NULL
activity	NULL
in	NULL
live	NULL
cells	NULL
and	NULL
tissue	NULL
.	NULL

In	NULL
:	NULL
Handbook	NULL
of	NULL
Fluorescent	NULL
Probes	NULL
and	NULL
Research	NULL
Chemicals	NULL
(	NULL
ed	NULL
.	NULL

M.T.Z	NULL
.	NULL

Spence	NULL
)	NULL
,	NULL
edn	NULL
6	NULL
,	NULL
p.	NULL
491	NULL
.	NULL

Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
.	NULL

Apkins	NULL
B.	NULL
,	NULL
Grane	NULL
A	NULL
.	NULL

&	NULL
Hamicton	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Up-regulation	NULL
of	NULL
murine	NULL
neonatal	NULL
T	NULL
helper	NULL
cell	NULL
responses	NULL
by	NULL
accessory	NULL
cell	NULL
factors	NULL
.	NULL

J	NULL
Immunol	NULL
153	NULL
,	NULL
3378	NULL
.	NULL

Roncaroto	NULL
M.	NULL
,	NULL
Biorer	NULL
M.	NULL
,	NULL
CiuT	NULL
E.	NULL
,	NULL
Martino	NULL
S.	NULL
&	NULL
Tovo	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Immune	NULL
responses	NULL
by	NULL
cord	NULL
blood	NULL
cells	NULL
.	NULL

Blood	NULL
Cell	NULL
20	NULL
,	NULL
573	NULL
.	NULL

Hassan	NULL
J.	NULL
,	NULL
O'Neit	NULL
S.	NULL
,	NULL
O'NzILL	NULL
L.A.J	NULL
.	NULL

,	NULL
Parrison	NULL
U	NULL
.	NULL

&	NULL
Reen	NULL
D.J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Signalling	NULL
via	NULL
CD28	NULL
of	NULL
human	NULL
naive	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
102	NULL
,	NULL
192	NULL
.	NULL

Kieinen	NULL
S.	NULL
,	NULL
Hentrinen	NULL
T.	NULL
,	NULL
Lanpenpowa	NULL
N.	NULL
,	NULL
HurkKoneN	NULL
J	NULL
.	NULL

&	NULL
Hurme	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Signals	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

S.	NULL
Kilpinen	NULL
&	NULL
M.	NULL
Hurme	NULL
transcription	NULL
factor	NULL
are	NULL
stronger	NULL
in	NULL
neonatal	NULL
than	NULL
adult	NULL
T	NULL
lymphocytes	NULL
.	NULL

Scand	NULL
J	NULL
Immunol	NULL
44	NULL
,	NULL
85	NULL
.	NULL

Trump	NULL
B.F.	NULL
&	NULL
BerEzesky	NULL
LK	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
role	NULL
of	NULL
cytosolic	NULL
Ca**	NULL
in	NULL
cell	NULL
injury	NULL
,	NULL
necrosis	NULL
and	NULL
apoptosis	NULL
.	NULL

Curr	NULL
Opin	NULL
Cell	NULL
Bio	NULL
!	NULL

4	NULL
,	NULL
227	NULL
.	NULL

Los	NULL
M.	NULL
,	NULL
Drogas	NULL
W.	NULL
&	NULL
ScHurze-OstHorr	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Inhibition	NULL
of	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
AP-1	NULL
by	NULL
CD28	NULL
signalling	NULL
in	NULL
human	NULL
T-cells	NULL
.	NULL

Biochem	NULL
J	NULL
302	NULL
,	NULL
119	NULL
.	NULL

ImBEeRT	NULL
V.	NULL
,	NULL
RupEc	NULL
R.A.	NULL
,	NULL
Livorst	NULL
A.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Tyrosine	NULL
phos-phorylation	NULL
of	NULL
IxB-	NULL
«	NULL
activates	NULL
NF-xB	NULL
without	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IxB-	NULL
«	NULL
.	NULL

Cell	NULL
86	NULL
,	NULL
787	NULL
.	NULL

Rosmson	NULL
A.T.	NULL
&	NULL
Aurexanper	NULL
D.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Regulation	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
and	NULL
p59	NULL
``	NULL
tyrosine	NULL
kinases	NULL
in	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
expressing	NULL
different	NULL
CD45	NULL
isoforms	NULL
.	NULL

In	NULL
:	NULL
Abstracts	NULL
of	NULL
the	NULL
British	NULL
Society	NULL
for	NULL
Immunology	NULL
,	NULL
p.	NULL
10	NULL
.	NULL

Brighton	NULL
,	NULL
UK	NULL
.	NULL

Rupp	NULL
C.E	NULL
.	NULL

,	NULL
Janssen	NULL
O.	NULL
,	NULL
Car	NULL
Y.	NULL
,	NULL
pa	NULL
Siva	NULL
AJ	NULL
.	NULL

,	NULL
Raas	NULL
M.	NULL
&	NULL
Prasap	NULL
KV.S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Two-step	NULL
TCRG/CD3-CD4	NULL
and	NULL
CD28	NULL
signalling	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
SH2/SH3	NULL
domains	NULL
,	NULL
protein-tyrosine	NULL
and	NULL
lipid	NULL
kinases	NULL
.	NULL

Immunol	NULL
Today	NULL
15	NULL
,	NULL
225	NULL
.	NULL

HoxasHt	NULL
N.	NULL
,	NULL
HayasHt	NULL
T.	NULL
,	NULL
Fusakt	NULL
N.	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
fyn	NULL
activates	NULL
transcription	NULL
from	NULL
the	NULL
HIV	NULL
promoter	NULL
via	NULL
activation	NULL
of	NULL
NF-xB-like	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Int	NULL
Immunol	NULL
7	NULL
,	NULL
1851	NULL
.	NULL

Rupp	NULL
C.E	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Upstream-downstream	NULL
:	NULL
CD28	NULL
cosignalling	NULL
pathways	NULL
and	NULL
T	NULL
cell	NULL
function	NULL
.	NULL

Immunity	NULL
4	NULL
,	NULL
527	NULL
.	NULL

ScHIEven	NULL
G.L	NULL
.	NULL

,	NULL
Kirmara	NULL
J.M	NULL
.	NULL

,	NULL
Myers	NULL
D.E	NULL
.	NULL

,	NULL
J.A	NULL
.	NULL

&	NULL
Uckun	NULL
FM	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
activate	NULL
NF-xB	NULL
in	NULL
a	NULL
tyrosine	NULL
kinase	NULL
dependent	NULL
mechanism	NULL
and	NULL
in	NULL
combination	NULL
with	NULL
vanadate	NULL
activate	NULL
the	NULL
p56**	NULL
and	NULL
p59	NULL
``	NULL
tyrosine	NULL
kinases	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Blood	NULL
82	NULL
,	NULL
1212	NULL
.	NULL

Jona	NULL
R.	NULL
,	NULL
Brouwer	NULL
M.	NULL
,	NULL
Miepema	NULL
F.	NULL
&	NULL
Lier	NULL
RA.W	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Human	NULL
CD8	NULL
*	NULL
T	NULL
lymphocytes	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
CD45RA	NULL
*	NULL
and	NULL
CD4SRO+*	NULL
cells	NULL
with	NULL
different	NULL
requirements	NULL
for	NULL
activation	NULL
and	NULL
differentiation	NULL
.	NULL

J	NULL
Immunol	NULL
146	NULL
,	NULL
2088	NULL
.	NULL

Kuper	NULL
H.	NULL
,	NULL
Brouwer	NULL
M.	NULL
,	NULL
oe	NULL
Boer	NULL
M.	NULL
,	NULL
ParREN	NULL
P.	NULL
&	NULL
van	NULL
Ler	NULL
R.A.W	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Differences	NULL
in	NULL
responsiveness	NULL
to	NULL
CD3	NULL
stimulation	NULL
between	NULL
naive	NULL
and	NULL
memory	NULL
CD4*	NULL
T	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
overcome	NULL
by	NULL
CD28	NULL
costimulation	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
24	NULL
,	NULL
1956	NULL
.	NULL

Suv	NULL
U.	NULL
,	NULL
Demeure	NULL
C.E	NULL
.	NULL

,	NULL
Byun	NULL
D.	NULL
,	NULL
Poprask1	NULL
F.	NULL
,	NULL
STERN	NULL
A.S.	NULL
&	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Interleukin	NULL
12	NULL
exerts	NULL
a	NULL
differential	NULL
effect	NULL
on	NULL
the	NULL
maturation	NULL
of	NULL
neonatal	NULL
and	NULL
human	NULL
CD4SRO~	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
94	NULL
,	NULL
1352	NULL
.	NULL

Hassan	NULL
J	NULL
.	NULL

&	NULL
Reen	NULL
D.J	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Cord	NULL
blood	NULL
CD4*	NULL
CD4SRA	NULL
*	NULL
T	NULL
cells	NULL
achieve	NULL
a	NULL
lower	NULL
magnitude	NULL
of	NULL
activation	NULL
when	NULL
compared	NULL
with	NULL
their	NULL
adult	NULL
counterparts	NULL
.	NULL

Immunology	NULL
90	NULL
,	NULL
397	NULL
.	NULL

LaHDENPOHJA	NULL
N.	NULL
&	NULL
Hurms	NULL
M.	NULL
(	NULL
1998	NULL
)	NULL
CD28-mediated	NULL
activation	NULL
in	NULL
CD4SRA*	NULL
and	NULL
CD45RO*	NULL
T	NULL
cells	NULL
:	NULL
enhanced	NULL
levels	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
and	NULL
c-Rel	NULL
nuclear	NULL
translocation	NULL
in	NULL
CD4SRA	NULL
*	NULL
cells	NULL
.	NULL

J	NULL
Leukocyte	NULL
Biol	NULL
,	NULL
in	NULL
press	NULL
.	NULL

©1998	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Immunology	NULL
,	NULL
94	NULL
,	NULL
167-172	NULL

